Inner eyelid surface temperature as a function of warm compress methodology
- PMID: 18677234
- DOI: 10.1097/OPX.0b013e318181adef
Inner eyelid surface temperature as a function of warm compress methodology
Abstract
Purpose: To (1) determine an optimal method of warm compress (WC) application to maximize heating meibomian glands in minimal time, (2) determine the maximum inner eyelid temperature achievable during 30 min of routine WC application, (3) examine the cooling curve for 10 min after WCs have been discontinued.
Methods: Subjects were randomly assigned to one of three WC methodologies. Group A (GrA), (n = 10): 15 min WC application without reheating. GrB, (n = 10): 30 min WC application with reheating every 2 min. GrC, (n = 12): 30 min WC application optimizing contact with the lower lid and reheating every 2 min. WCs were heated to 45 +/- 0.5 degrees C. Outer and inner lower eyelid surface temperatures were measured at baseline and regular intervals.
Results: GrA: the maximum outer and inner lower eyelid surface temperatures = 41.2 +/- 0.3 degrees C at 1 min and 38.8 +/- 0.2 degrees C after 4 min, respectively. GrB: the maximum outer upper eyelid temperature, 43.3 +/- 0.5 degrees C, was reached after 6 min while it required 30 min to reach the maximum inner lower eyelid temperature, 40.4 +/- 0.3 degrees C. GrC: it required 4 min to reach the maximum outer lower eyelid temperature, 42.2 +/- 0.4 degrees C, while it required 20 min to reach the maximum inner lower eyelid temperature, 40.8 +/- 0.3 degrees C.
Conclusions: To optimize WC efficiency, patients should (1) heat the WC to approximately 45 degrees C, (2) optimize contact between the WC and outer eyelid surfaces, (3) reheat the WC frequently and have a replacement heated WC on hand for exchange, and (4) perform the activity for at least 4 min in order to achieve an inner lower eyelid temperature > or = 40 degrees C. Longer therapy may be necessary for more severe obstructions. These data suggest that precise, customized, labor-intensive WC procedure is necessary to optimize treating meibomian gland dysfunction and obstruction using WCs.
Similar articles
-
Warm compresses and the risks of elevated corneal temperature with massage.Cornea. 2013 Jul;32(7):e146-9. doi: 10.1097/ICO.0b013e318292a7b7. Cornea. 2013. PMID: 23665651
-
All Warm Compresses Are Not Equally Efficacious.Optom Vis Sci. 2015 Sep;92(9):e327-33. doi: 10.1097/OPX.0000000000000675. Optom Vis Sci. 2015. PMID: 26164316
-
Temperature profiles of patient-applied eyelid warming therapies.Cont Lens Anterior Eye. 2015 Dec;38(6):430-4. doi: 10.1016/j.clae.2015.06.002. Epub 2015 Jun 27. Cont Lens Anterior Eye. 2015. PMID: 26126722
-
Hot towels: The bedrock of Meibomian gland dysfunction treatment - A review.Cont Lens Anterior Eye. 2023 Apr;46(2):101775. doi: 10.1016/j.clae.2022.101775. Epub 2022 Oct 28. Cont Lens Anterior Eye. 2023. PMID: 36715292 Review.
-
Role of EGF receptor signaling on morphogenesis of eyelid and meibomian glands.Exp Eye Res. 2017 Oct;163:58-63. doi: 10.1016/j.exer.2017.04.006. Exp Eye Res. 2017. PMID: 28950938 Free PMC article. Review.
Cited by
-
Evidence-Based Strategies for Warm Compress Therapy in Meibomian Gland Dysfunction.Ophthalmol Ther. 2024 Sep;13(9):2481-2493. doi: 10.1007/s40123-024-00988-x. Epub 2024 Jul 11. Ophthalmol Ther. 2024. PMID: 38990464 Free PMC article.
-
The sustained effect (12 months) of a single-dose vectored thermal pulsation procedure for meibomian gland dysfunction and evaporative dry eye.Clin Ophthalmol. 2016 Jul 26;10:1385-96. doi: 10.2147/OPTH.S109663. eCollection 2016. Clin Ophthalmol. 2016. PMID: 27555745 Free PMC article.
-
Assessing clinical and molecular outcomes of prophylactic thermal pulsation therapy on ocular surface health following refractive surgery.Indian J Ophthalmol. 2023 Apr;71(4):1508-1516. doi: 10.4103/IJO.IJO_3361_22. Indian J Ophthalmol. 2023. PMID: 37026292 Free PMC article.
-
TheraPearl Eye Mask and Blephasteam for the treatment of meibomian gland dysfunction: a randomized, comparative clinical trial.Sci Rep. 2021 Nov 17;11(1):22386. doi: 10.1038/s41598-021-01899-8. Sci Rep. 2021. PMID: 34789807 Free PMC article. Clinical Trial.
-
TearCare® system extension study: evaluation of the safety, effectiveness, and durability through 12 months of a second TearCare® treatment on subjects with dry eye disease.Clin Ophthalmol. 2019 Jan 22;13:189-198. doi: 10.2147/OPTH.S191588. eCollection 2019. Clin Ophthalmol. 2019. PMID: 30774298 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources